Genomic data is transforming precision medicine—but progress depends on it being easily available where it’s needed. Pharmaceutical Executive speaks to Ignacio Medina, founder of Cambridge University spinout Zetta Genomics, to see how next-generation open-source data technologies accelerate discovery in the lab and patient benefit in the clinic.
Augustin, a Senior Creative Strategist at Artemis Ward, leads the PhRMA account and provides a strategic lens to the overall work.
Rush shares his thoughts on how advanced analytics are making their mark on the pharma industry.
OCE+ is the first of several new advancements to IQVIA's leading life science customer engagement platform.
In this newly created role, Peter will drive the overall impact of the agency’s work by infusing breakthrough creativity and insight-informed strategy across the business.
Brennan describes what her career journey in pharma has looked like as a woman, and what she feels can be done to improve opportunities for other females in pharma. She also talks about how advocacy and commitment can similarly be applied to improve the rare disease space.
Mazur talks about his commitment to drug development and what it takes to succeed in the industry today.
Kinsella will initially be charged with building out the multilingual team and service across Europe, North & South America while forging new relationships with meeting and events owners in those territories.
Witkos discusses her achievements during her first year as SVP, International Region head, and her long-term goals in helping to maintain Alnylam’s leadership in the RNAi field.
Q&A with Hettie Stroebel, Founder and CEO of Launch Excellence.
Insights. How can pharma companies solve the insights gap through better insights management?
Q&A with Ross Krentzman, VP of Sales at Intersection, to discuss the growth and development of digital in out-of-home (OOH) advertising over the past couple of years.
Ed Thesiger is promoted to lead the agency through the next phase of growth.
Analytics technology from CloudMedx can revolutionize chronic care management and planning in every community.
Liz Kane named Chief Strategy Officer, Corina Kellam promoted to new role leading recently formed Experience & Innovation Team.
Accolades Confirm Intouch as Among the Fastest-Rising Creative Agencies in the World.
Research evaluated value and impact of digital tools on outcomes and patient experience.
Examples of these restructurings include the shifting of product priorities, creation of new business units, consolidations of sales full-time equivalents (FTEs), adjustments of leadership positions, and layoffs. One major change, in particular, is the realignment of sales teams as a response to newly approved indications.
Pamela Stahl joins as Chief Commercial Officer (CCO) and President, North America to lead Sidekick's global commercial strategy, and Mitchell Mudra joins Sidekick as Chief Operating Officer (COO).
Titus will lead next phase of business expansion for epocrates.
With a background in both the biopharma industry and marketing, Megjugorac brings a unique perspective to bioscience communications.
Evoke, a leading global health and wellness agency, announced today the integration with San Francisco-based Evoke Giant to build a seamless North American client partner.
Acquisition expands Glooko's digital health capabilities with machine learning.
Cody Ware, who lives with migraine, re-signs as driver of Nurtec ODT No. 51 car for the NASCAR Cup Series and two-time INDY 500 Champion Takuma Sato joins the Nurtec ODT No. 51 car. In addition, Biohaven and Rick Ware Racing continue the Military Salutes Program to drive awareness of migraine among active-duty service members, veterans and their families
AI has the potential to revolutionize the pharma marketing industry. Pharma should look to harness its power to capture important data and insights to better engage HCPs through personalized, smart messaging.
DeepIntent’s patient-modeled audiences solution uses comprehensive real-world clinical datasets to precisely reach patient populations, including those facing rare diseases and low prevalence conditions.
Cernese shares his perspectives on the increasing demand for quick, accessible health information, the subsequent pressure this puts on the highly regulated life sciences industry, and how artificial intelligence (AI), the use of machine learning to perform tasks that traditionally rely on human intelligence, can help.
The acquisition immediately propels EVERSANA’s position as a commercial services leader worldwide, poised to solve any global pricing, access, reimbursement, promotion, adherence, or product delivery challenge.
The acquisition will bolster Fingerpaint’s omnichannel offering, data and analytics capabilities, and global presence.
Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced it acquired MedThink, a North Carolina–based company that empowers healthcare providers through medical communications.